ctrl K

Price Alert

Lixte Biotechnology Inc. (LIXT)

NASDAQ: LIXT · Real-Time Price · USD

3.56

-0.34 (-8.72%)

At close: Aug 15, 2025, 3:59 PM

3.62

1.69%

After-hours: Aug 15, 2025, 05:16 PM EDT

Lixte Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.04M	4.2M	5.35M	4.82M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	106.55K	n/a	147.02K	150.24K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	-106.55K	n/a	-970	10.25K
Total Current Assets	1.04M	4.31M	5.56M	5.09M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	106.55K	n/a	147.02K	150.24K
Total Assets	1.15M	4.31M	5.56M	5.09M
Account Payables	83.21K	120.51K	183.75K	225.97K
Deferred Revenue	235.08K	157.1K	165.02K	76.96K
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	-970	n/a
Total Current Liabilities	318.28K	313.86K	394.79K	302.93K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Liabilities	318.28K	313.86K	394.79K	302.93K
Total Debt	n/a	n/a	n/a	n/a
Common Stock	225.00	225.00	1.66K	1.37K
Retained Earnings	-52.07M	-48.48M	-43.39M	-37.08M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	827.22K	3.99M	5.17M	4.79M
Total Investments	n/a	n/a	n/a	n/a